Acro Biomedical (ACBM) Other Operating Expenses (2015 - 2023)
Acro Biomedical's quarterly Other Operating Expenses came in at $492000.0 in Q3 2023, up 6592.97% quarter-over-quarter from $7351.0 in Q4 2016.
Acro Biomedical has reported Other Operating Expenses for 3 years, with the latest figure at $492000.0 in Q3 2023.
- For the quarter ending Q3 2023, Other Operating Expenses changed N/A year-over-year to $492000.0; the trailing twelve-month figure through Jun 2024 stood at $492000.0 (changed N/A YoY), and the FY2023 full-year result was $492000.0, changed N/A from the prior year.
- Other Operating Expenses for Q3 2023 stood at $492000.0, up from $7351.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $492000.0 in Q3 2023, with the low at $492000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 492,000.00 |
| Dec 31, 2016 | 7,351.00 |
| Sep 30, 2016 | 5,141.00 |
| Jun 30, 2016 | 17,107.00 |
| Mar 31, 2016 | 6,332.00 |
| Dec 31, 2015 | 13,793.00 |
| Sep 30, 2015 | 2,325.00 |